Relation between a spleen-derived immunosuppressive peptide and the immunoglobulin-binding factor.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001666:Binding Sites, Antibody; D002846:Chromatography, Affinity; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D007108:Immune Tolerance; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000096:biosynthesis / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000302:isolation & purification*; D008222:Lymphokines / Q000302:isolation & purification*; D051379:Mice; D010455:Peptides / Q000302:isolation & purification / Q000494:pharmacology*; D011485:Protein Binding; D013491:Suppressor Factors, Immunologic
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D008222:Lymphokines; D010455:Peptides; D013491:Suppressor Factors, Immunologic; C029640:spleen derived immunosuppressive peptide